Past, Present, and Future Research on the Lung Microbiome in Inflammatory Airway Disease

Overview

Journal Chest

Publisher Elsevier

Specialty Pulmonary Medicine

Date 2019 Jun 3

PMID 31154042

Citations 28

Authors

Lindsay J Caverly

Yvonne J Huang

Marc A Sze

Affiliations

Soon will be listed here.

Abstract

COPD, asthma, and cystic fibrosis (CF) are obstructive lung diseases with distinct pathophysiologies and clinical phenotypes. In this paper, we highlight recent advances in our understanding of relationships between clinical phenotypes, host inflammatory response, and lung microbiota in these diseases. Although COPD, asthma, and CF largely have distinct lung microbiota and inflammatory profiles, certain commonalities exist. In all three of these lung diseases, and in healthy persons, anaerobic taxa that are typically associated with oral microbiota (eg, Prevotella species, Veillonella species) are present in the airways and associated with increased host inflammatory response. Similarly, across all three diseases, members of the Proteobacteria phylum are associated with more advanced disease. Finally, we highlight challenges in translating these findings into advances in clinical care, including continued knowledge gaps regarding the causal relationships between host inflammatory response, lung microbiota, medication effects, and clinical phenotypes.

Citing Articles

Amelioration of Inflammation in Rats with Experimentally Induced Asthma by Trimen Polyphenols via the PI3K/Akt Signaling Pathway.

Xia Z, Zhao X, Wang L, Huang L, Yang Y, Yin X Int J Mol Sci. 2025; 26(1.

PMID: 39796021 PMC: 11720363. DOI: 10.3390/ijms26010165.

Microbiome and metabolome patterns after lung transplantation reflect underlying disease and chronic lung allograft dysfunction.

Martin C, Mahan K, Wiggen T, Gilbertsen A, Hertz M, Hunter R Microbiome. 2024; 12(1):196.

PMID: 39385282 PMC: 11462767. DOI: 10.1186/s40168-024-01893-y.

A metagenomic next-generation sequencing (mNGS)-based analysis of bronchoalveolar lavage samples in patients with an acute exacerbation of chronic obstructive pulmonary disease.

Wu J, Zhang Y, Duan J, Wei Y, Miao Y J Mol Histol. 2024; 55(5):709-719.

PMID: 39060894 DOI: 10.1007/s10735-024-10225-1.

Cross-domain microbiomes: the interaction of gut, lung and environmental microbiota in asthma pathogenesis.

Zhang J, Zheng X, Luo W, Sun B Front Nutr. 2024; 11:1346923.

PMID: 38978703 PMC: 11229079. DOI: 10.3389/fnut.2024.1346923.

Comparison of the upper and lower airway microbiome in early postoperative lung transplant recipients.

Li C, Lv M, Liu H, Lin Y, Pan J, You C Microbiol Spectr. 2024; 12(6):e0379123.

PMID: 38747583 PMC: 11237413. DOI: 10.1128/spectrum.03791-23.

References

Bosch A, de Steenhuijsen Piters W, van Houten M, Chu M, Biesbroek G, Kool J . Maturation of the Infant Respiratory Microbiota, Environmental Drivers, and Health Consequences. A Prospective Cohort Study. Am J Respir Crit Care Med. 2017; 196(12):1582-1590. DOI: 10.1164/rccm.201703-0554OC. View

Woodruff P, Barr R, Bleecker E, Christenson S, Couper D, Curtis J . Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. N Engl J Med. 2016; 374(19):1811-21. PMC: 4968204. DOI: 10.1056/NEJMoa1505971. View

Segal L, Alekseyenko A, Clemente J, Kulkarni R, Wu B, Gao Z . Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome. 2014; 1(1):19. PMC: 3971609. DOI: 10.1186/2049-2618-1-19. View

Sze M, Dimitriu P, Suzuki M, McDonough J, Campbell J, Brothers J . Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2015; 192(4):438-45. PMC: 4595667. DOI: 10.1164/rccm.201502-0223OC. View

Carmody L, Zhao J, Schloss P, Petrosino J, Murray S, Young V . Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc. 2013; 10(3):179-87. PMC: 3960905. DOI: 10.1513/AnnalsATS.201211-107OC. View

Mercado-Blanco J, Abrantes I, Caracciolo A, Bevivino A, Ciancio A, Grenni P . Belowground Microbiota and the Health of Tree Crops. Front Microbiol. 2018; 9:1006. PMC: 5996133. DOI: 10.3389/fmicb.2018.01006. View

Coburn B, Wang P, Diaz Caballero J, Clark S, Brahma V, Donaldson S . Lung microbiota across age and disease stage in cystic fibrosis. Sci Rep. 2015; 5:10241. PMC: 4431465. DOI: 10.1038/srep10241. View

Erb-Downward J, Thompson D, Han M, Freeman C, McCloskey L, Schmidt L . Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One. 2011; 6(2):e16384. PMC: 3043049. DOI: 10.1371/journal.pone.0016384. View

Barcik W, Pugin B, Westermann P, Rodriguez Perez N, Ferstl R, Wawrzyniak M . Histamine-secreting microbes are increased in the gut of adult asthma patients. J Allergy Clin Immunol. 2016; 138(5):1491-1494.e7. DOI: 10.1016/j.jaci.2016.05.049. View

10.

Frayman K, Wylie K, Armstrong D, Carzino R, Davis S, Ferkol T . Differences in the lower airway microbiota of infants with and without cystic fibrosis. J Cyst Fibros. 2018; 18(5):646-652. PMC: 6586525. DOI: 10.1016/j.jcf.2018.12.003. View

11.

Boetius A, Anesio A, Deming J, Mikucki J, Rapp J . Microbial ecology of the cryosphere: sea ice and glacial habitats. Nat Rev Microbiol. 2015; 13(11):677-90. DOI: 10.1038/nrmicro3522. View

12.

Carmody L, Caverly L, Foster B, Rogers M, Kalikin L, Simon R . Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis. PLoS One. 2018; 13(3):e0194060. PMC: 5844593. DOI: 10.1371/journal.pone.0194060. View

13.

Zemanick E, Wagner B, Robertson C, Stevens M, Szefler S, Accurso F . Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods. Ann Am Thorac Soc. 2014; 12(2):221-9. PMC: 4342834. DOI: 10.1513/AnnalsATS.201407-310OC. View

14.

Ownby D, Johnson C, Peterson E . Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age. JAMA. 2002; 288(8):963-72. DOI: 10.1001/jama.288.8.963. View

15.

Bhatt S, Soler X, Wang X, Murray S, Anzueto A, Beaty T . Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2016; 194(2):178-84. PMC: 5003216. DOI: 10.1164/rccm.201511-2219OC. View

16.

Ronan N, Einarsson G, Twomey M, Mooney D, Mullane D, NiChroinin M . CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores After CFTR Modulation With Ivacaftor. Chest. 2017; 153(2):395-403. DOI: 10.1016/j.chest.2017.10.005. View

17.

Huang Y, Nariya S, Harris J, Lynch S, Choy D, Arron J . The airway microbiome in patients with severe asthma: Associations with disease features and severity. J Allergy Clin Immunol. 2015; 136(4):874-84. PMC: 4600429. DOI: 10.1016/j.jaci.2015.05.044. View

18.

Huang Y, Kim E, Cox M, Brodie E, Brown R, Wiener-Kronish J . A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS. 2010; 14(1):9-59. PMC: 3116451. DOI: 10.1089/omi.2009.0100. View

19.

Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E . Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol. 2001; 107(1):129-34. DOI: 10.1067/mai.2001.111237. View

20.

Khan T, Wagener J, Bost T, Martinez J, Accurso F, Riches D . Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995; 151(4):1075-82. DOI: 10.1164/ajrccm/151.4.1075. View